Literature DB >> 8751023

Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.

J Lundahl1, C G Regårdh, B Edgar, G Johnsson.   

Abstract

In this randomised, cross-over study, in nine healthy males given felodipine ER 10 mg PO 200 ml grapefruit juice was found to increase the plasma levels of felodipine even when the juice was taken 24 hours before the drug. Grapefruit juice drunk simultaneously with and 1, 4, 10 or 24 hours before the drug administration resulted in a 32-99% increase in mean Cmax values of felodipine, relative to concomitant water and felodipine intake. The effect on AUC was also significant when juice was taken up to 10 h before the drug. The effect of the interaction decreased with increasing time between juice and drug intake. All treatments produced a significant decrease in diastolic blood pressure and an increase in heart rate in comparison with morning basal values. The change in haemodynamic variables was approximately the same after all treatment combinations. Headache was reported more frequently after treatments including grapefruit juice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751023     DOI: 10.1007/bf00192360

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

2.  In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

Authors:  F P Guengerich; D H Kim
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

3.  The trans-hepatic extraction of nifedipine.

Authors:  V F Challenor; D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

4.  Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.

Authors:  U G Eriksson; J Lundahl; C Bäärnhielm; C G Regårdh
Journal:  Drug Metab Dispos       Date:  1991 Sep-Oct       Impact factor: 3.922

Review 5.  The flavonoids. A class of semi-essential food components: their role in human nutrition.

Authors:  J Kühnau
Journal:  World Rev Nutr Diet       Date:  1976       Impact factor: 0.575

6.  Felodipine kinetics in healthy men.

Authors:  B Edgar; C G Regårdh; G Johnsson; L Johansson; P Lundborg; I Löfberg; O Rönn
Journal:  Clin Pharmacol Ther       Date:  1985-08       Impact factor: 6.875

7.  Pharmacokinetics of felodipine in patients with liver disease.

Authors:  C G Regårdh; B Edgar; R Olsson; M Kendall; P Collste; C Shansky
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

Authors:  C Bäärnhielm; H Dahlbäck; I Skånberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-08

9.  Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.

Authors:  J van Harten; P van Brummelen; J H Wilson; M T Lodewijks; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin.

Authors:  D G Bailey; J M Arnold; C Munoz; J D Spence
Journal:  Clin Pharmacol Ther       Date:  1993-06       Impact factor: 6.875

View more
  26 in total

1.  Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors:  H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

2.  Grapefruit juice: potential drug interactions.

Authors:  James Maskalyk
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

3.  Drug-phytochemical interactions.

Authors:  Costas Ioannides
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

4.  Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.

Authors:  Gareth E Lim; Timao Li; Harpal S Buttar
Journal:  Exp Clin Cardiol       Date:  2003

5.  Effect of grapefruit juice on clarithromycin pharmacokinetics.

Authors:  K L Cheng; A N Nafziger; C A Peloquin; G W Amsden
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 6.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

7.  Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.

Authors:  Ezra E W Cohen; Kehua Wu; Christine Hartford; Masha Kocherginsky; Kimberly Napoli Eaton; Yuanyuan Zha; Anitha Nallari; Michael L Maitland; Kammi Fox-Kay; Kristin Moshier; Larry House; Jacqueline Ramirez; Samir D Undevia; Gini F Fleming; Thomas F Gajewski; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2012-08-07       Impact factor: 12.531

8.  Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults.

Authors:  Ronald de Vries; Johan W Smit; Peter Hellemans; James Jiao; Joseph Murphy; Donna Skee; Jan Snoeys; Juthamas Sukbuntherng; Maarten Vliegen; Loeckie de Zwart; Erik Mannaert; Jan de Jong
Journal:  Br J Clin Pharmacol       Date:  2016-01-15       Impact factor: 4.335

Review 9.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

10.  Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.

Authors:  Vibeke Andersen; Natalie Pedersen; Niels-Erik Larsen; Jesper Sonne; Steen Larsen
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.